We are delighted to announce the launch of our new Optimise programme, Best-value biological medicines: Focus on the position of biosimilar medicines.
As part of NHS England’s Medicines Value Programme, pharmacy professionals will need to be able to support patients and other healthcare professionals with the increasing use of best-value biological medicines, such as insulins and low-molecular-weight herapins.
Our Optimise programme will help you to apply a person-centred approach and improve your confidence when discussing the use of best-value biological medicines, including biosimilar medicines.
Completing this programme will enable you to discuss the benefits and challenges of using best-value biological medicines in order to support decision making by clinicians, as well as explain the differences in the regulatory approval process for biosimilar medicines compared to biological and generic medicines.
Our Optimise programmes are ideal if you work in a clinical setting and are looking to have a quick learning session with your colleagues. The programme should take around one hour to complete with 20 minutes for pre-work and 40 minutes of learning activities.
For more information and to access the learning, click here.